Almost a year after having seen his vaccine approved by the health authorities, Stéphane Bancel, CEO of Moderna, returns for
Le Figaro
on the incredible journey of his company.
In 2021, the biotech founded in 2010, which had never marketed a treatment before the Covid, will have delivered more than 700 million vaccines and plans to deliver up to 3 billion next year.
LE FIGARO.
- Between the fifth wave sweeping over part of the globe and the new Omicron variant, it's double trouble ...
Stéphane BANCEL.
-
The appearance of Omicron is a real concern because of the large number of mutations it contains and which would make it very contagious.
It is possible that the existing vaccines are much less effective against this variant, we will know more in the coming weeks.
Moderna started a study on November 24 with a view to developing a new version of its booster adapted to the Omicron variant.
It will take 60 to 90 days to achieve this.
Read also
Could the Omicron variant be "good news"?
Technology
This article is for subscribers only.
You have 92% left to discover.
To cultivate one's freedom is to cultivate one's curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/EEJSWJ3MT5C2LL4U4EDDVAF3FY.jpg)
